While political and legal attempts to repeal the Patient Protection and Affordable Care Act may draw the most attention, the real success or failure of the law will play out in hundreds of regulatory battles that will take place largely out of the public

More calls for shoring up safety gaps in the safety of the U.S. drug supply came from the Hill this week in the wake of a wide recall of children's medicines. Congresswoman Rosa DeLauro (D-CT), a frequent advocate for better drug and food safety, has join

When Older Americans Month was established 47 years ago, only 17 million living Americans had reached their 65th birthdays. Today, there are nearly 40 million adults age 65 and older. And when the first baby boomers turn age 65 in 2011 they will become e

For those who haven't read it, Ed Silverman over at Pharmalot has a great interview with former FDA associate chief counsel and former Pfizer senior counsel Arnie Friede, about the new "BadAd" program that FDA's Division of Drug Marketing, Advertising and

Back in 2005, [Manny] Lanza was diagnosed with arteriovenous malformation, a serious brain condition. He had been working 50 hours a week at a fast food restaurant, but his job was considered part-time and his employer did not offer him health insurance.

Throughout the debate on passage, pollsters regularly found that the public wanted a “bipartisan solution” to health reform. Of course, no such solution was forthcoming if by bipartisan we mean something that attracts votes from members of both parties. A

Roughly two-thirds of patients believe it’s important to know a physician’s ties to a pharmaceutical company, and between 27 percent and 56 percent believe that such ties affect prescribing. Those are some of the findings from a systematic review in the c

The FDA has delayed announcing its new pediatric cough and cold medicine dosing guidelines, according to the Tan Sheet. The guidelines were due to be released in June 2010, but have been pushed to December 2010. The chief catalyst for the revised guidelin

With Enemies Like This, Who Needs Friends? As they tried to regain their footing after the surprise Senate election of Scott Brown, reformers received an unexpected boost from for-profit insurer Wellpoint. In February, the insurance giant announced it was